Development and Internal Validation of a Nomogram for Identifying Postpartum Fatigue in Postpartum Women: A Cross‐Sectional Study
Nursing Open · 2026-10 · 13 (10)
DOI: 10.1002/nop2.70907 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Nursing Open, online erschienen am 09.10.2026. Verfasst von Zhidong Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Nomograms, Fatigue, Postpartum Period. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
To identify factors associated with postpartum fatigue in postpartum women and to develop and internally validate a clinical nomogram.
Design
A cross‐sectional study.
Methods
This cross‐sectional study recruited 780 postpartum women via convenience sampling at a tertiary hospital in Guangdong, China (January–May 2025). After excluding invalid questionnaires, 744 participants were randomly allocated (7:3) to derivation and internal validation sets. Data were collected using a general information questionnaire and validated scales for postpartum fatigue, depression and social support. Candidate factors were pre‐specified based on clinical relevance and previous evidence. LASSO regression was used for variable selection. Model performance was assessed using the AUC, calibration plots, the Hosmer‐Lemeshow test and decision curve analysis (DCA), with internal validation by randomly splitting the sample into derivation and internal validation sets.
Results
Among the 744 postpartum women, the prevalence of postpartum fatigue was 69.0% ( n = 513). Four independent factors were associated with postpartum fatigue: postpartum depression, maternal sleep quality, breastfeeding ability and intrapartum blood loss. The nomogram showed good discrimination in both the derivation (AUC = 0.821) and internal validation (AUC = 0.801) sets. At the optimal cut‐off of 0.682, sensitivity and specificity were 75.2% and 76.8%, respectively. The Hosmer‐Lemeshow test confirmed good calibration in both sets (derivation: χ 2 = 8.949, p = 0.3466; internal validation: χ 2 = 4.422, p = 0.8172). DCA indicated favourable clinical net benefit across a relevant range of thresholds.
Conclusions
We developed and internally validated a practical nomogram for identifying postpartum fatigue using readily available clinical and psychosocial factors. The model showed good performance.
Implications for Nursing
Practice This nomogram may assist nurses and midwives in early identification of postpartum women at increased likelihood of fatigue and facilitate individualized nursing interventions to improve postpartum recovery. Patient or Public Contribution No patient or public contribution was made to the design, conduct, analysis, interpretation or writing of this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
- Nursing Department, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
ORCID-Profile: Zhidong Guo, Min Xu, Shouzhen Cheng
Zitieren
APA
Guo, Z., Xu, M., & Cheng, S. (2026). Development and Internal Validation of a Nomogram for Identifying Postpartum Fatigue in Postpartum Women: A Cross‐Sectional Study. Nursing Open, 13(10). https://doi.org/10.1002/nop2.70907
Vancouver
Guo Z, Xu M, Cheng S. Development and Internal Validation of a Nomogram for Identifying Postpartum Fatigue in Postpartum Women: A Cross‐Sectional Study. Nursing Open. 2026;13(10). doi:10.1002/nop2.70907
BibTeX
@article{Guo2026,
author = {Guo, Zhidong and Xu, Min and Cheng, Shouzhen},
title = {Development and Internal Validation of a Nomogram for Identifying Postpartum Fatigue in Postpartum Women: A Cross‐Sectional Study},
journal = {Nursing Open},
year = {2026},
volume = {13},
number = {10},
doi = {10.1002/nop2.70907}
}
EUVIMED